2011 PROGRAMME HIGHLIGHTS
Photos of PACTRIMS 2011
Opening Ceremony | Clinical Seminar | Award Ceremony | Misc PACTRIMS 2011 Photos
Please click here for the latest detailed programme.
28 Aug Sun
Opening Ceremony
Opening Remarks (Thirugnanam Umapathi)
Special Guest Remarks (Sylvia Lim)
PACTRIMS Executive Committee President Remarks (Takahiko Saida)
Invited Lecture-1 (Plenary)
Chair: Thirugnanam Umapathi
1. Evolving Concepts in the Pathogenesis of NMO and Related Syndromes (Hans Lassmann)
PACTRIMS Topics 1 (Plenary)
Co-Chairs: Hossein Pakdaman; Bimsara Senanayake
NMO in SouthEast Asia
1. AQP4 antibody-positive Thai Cases: Clinical and Diagnostic Problems (Sasitorn Siritho)
2. NMO in Singapore (Kevin Tan)
3. Optic Manifestations of NMO (Sharon Tow)
PACTRIMS Topics 2 (Plenary)
Chair: Alvin Seah
Connexins in Demyelinating Disorders (Jun-ichi Kira, Masaki Katsuhisa)
PACTRIMS Basic Science Lecture
Chair: Akio Suzumura
Origin and Homeostasis of Brain Microglia (Florent Ginhoux)
Pharma-sponsored Seminar 1
Betaferon®: A Focus for Life, Experience for More Than Two Decades (Bayer Healthcare)
29 Aug Mon
Pharma-sponsored Seminar 2
Treatment Options for Patients with Multiple Sclerosis (Biogen Idec)
Main Symposium-1
(Plenary)
Co-Chairs: Allan Kermode, Xian-Hao Xu
Large-Scale Genetic Studies in MS
1. What do Large-scale Genetic Studies on MS tell us about the Mechanism? (Jorge R Oksenberg)
2. Genetic Studies of MS in Indians (Lekha Pandit)
3. Genetic Studies of MS in Chinese & Australians (Qiu Wei, Allan Kermode)
4. Genetic Background of Recent Increase of MS in Japanese (Noriko Isobe, Jun-ichi Kira)
Invited Lecture 2 (Plenary)
Chair: Patrick Li
New Diagnostic Criteria for MS: 2010 revisions (Kazuo Fujihara)
Invited Lecture 3 (Plenary)
Chair: Goh Kong Yong
Emerging Therapies and Optimizing of Treatment for MS (William Carroll)
Main symposium-2 (Plenary)
Co-Chairs: Kwang-Ho Lee, Ernest Willoughby
Optimization of Treatments for MS and NMO in Asians
1. Clinical Trial Results of Emerging New Disease-modifying Therapies for MS in Japanese (Takahiko Saida)
2. Optimisation of Treatment for NMO in Asians (Ho Jin Kim)
3. Treatment of LESCLs with Special Reference to IFNb Responsiveness in CMS with LESCL and NMO with LESCL (Ching-Piao Tsai)
Pharma-sponsored Seminar 3
Optimizing Outcomes through Early Multiple Sclerosis Treatment (Merck Serono)
30 Aug Tue
Pharma-sponsored Seminar 4
Fingolimod: MS Treatment Transformation (Novartis)
Main symposium-3 (Parallel)
Co-Chairs: William Carroll, Qi Cheng
Contributions of Environmental Factors to Demyelinating Diseases
1. Environmental Influence on MS (Bruce Taylor)
2. Herpes Viruses and Genetic Epistasis in MS (David Nolan)
3. Vitamin D Deficiency and Increase of MS Prevalence in Iran (Masoud Etemadifar)
4. HTLV-1 Infection and Development of Demyelinating Diseases (Fujio Umehara)
PACTRIMS Clinical Seminar: (Parallel)
Co-Chairs: Benjamin Ong, Naraporn Prayoonwiwat
Atypical Manifestations of MS and NMO in Asians: An Interactive Case Discussion
1. [P-84] A Case of Multiple Sclerosis Presenting as Lateral Rectus Palsy: A Case Report – (Johnna De Jose)
2. [P-104] Posterior Scleritis Mimicking Optic Neuritis in a Young Female Patient – (Katherine Lun)
3. [P-86] Tumefactive MS in Hospital Kuala Lumpur – (Joyce Joseph)
4. [P-100] Biopsy Proven CNS Aquaporin-4 Autoimmunity Presenting with an Isolated Brain Abnormality – (Su-Hyun Kim)
5. [P-103] Intracranial Germinoma Initially Mimicking Brain Abnormalities Of Neuromyelitis Optica (NMO): A Case Report – (Shintaro Hayashi)
6. [P-102] Adult-onset Alexander Disease Mimicking Neuromyelitis Optica - (Tai-Seung Nam)
7. [P-105] A Progressive Cryptogenic Necrotizing Rhomboencephalitis - (Byoung-Soo Shin)
Award Ceremony & Closing Remarks